Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

ICYMI: New era of medicine initiative kicks off in Boston

February 22, 2017

New Era of Medicine initiative kicks off in Boston.

Read More

Exploring the new era of medicine

February 21, 2017

We are in a new era of medicine where innovations are transforming our ability to attack the cause of disease, not just the symptoms.

Read More

PhRMA Kicks Off National Health Care Dialogue to Examine the New Era of Medicine

February 21, 2017

PhRMA will sponsor its first national health care dialogue series today in Boston, Massachusetts.

Read More

Medicare Monday: Have you heard of CMMI?

February 20, 2017

What is the Center for Medicare and Medicaid Innovation and concerns with its structure.

Read More

ICYMI – 3 new reports show dramatic slowdown in medicine spending growth

February 17, 2017

Newly released data confirm previous projections of significant decline in medicine spending growth.

Read More

What you don’t know about importation from Canada

February 17, 2017

Infographic explores the realities of importation, comparing what you think happens in Canada with what actually happens.

Read More

Biopharmaceutical industry’s success reducing disparities for African Americans

February 16, 2017

Looking at bipharmaceutical industry's success in reducing disparities for African Americans for Black History Month

Read More

Guest Post: Johnson and Johnson is celebrating outstanding scientists: Who will be next?

February 15, 2017

One way that Johnson & Johnson supports and celebrates the role of scientists in advancing human health is the Dr. Paul Janssen Award for Biomedical Research.

Read More

Watch: Biomarkers in drug development with Dr. Bernie Zeiher

February 14, 2017

Biomarkers are tools used by medical professionals in many ways, including in the diagnosis of disease, disease progress and how the body is responding.

Read More

Discovery of counterfeit hepatitis C drug is another example of why importation is bad for patients

February 13, 2017

Discovery of counterfeit hepatitis C drug is another example of why importation is bad for patients

Read More